- Get link
- X
- Other Apps
North Carolina: Type 2 diabetics have to take the vaccination of daily insulin which is a painful process, but experts now having one to two times the insulin injection thanks to which it has devised a way months are enough and patients will not have to undergo this torture every day.
Diabetes Like some glukugan 'in modern medicine peptides 1' or short 'GLP-1 (GLP1), called it a molecule which caused additional glucose amount that increases production of insulin in the body and thus the amount of blood sugar is controlled.
If, despite your best features GLP-1 when it reaches the human body is split over very quickly and thus unable to take advantage. Although GLP is to increase the sustainability of some of the more molecules (molecules) with 1 but then it ends dissolve within 3 to 7 days.
But under the new approach, scientists have GLP-1 can maintain its existence for more than two weeks in a body that is made to it, and that a long type 2 diabetics from insulin injection can be found.
Research journal 'Nature Biomedical Engineering, according to a report published in North Carolina, USA Duke University, a private research institute experts have been jointly working GLP 1 is combined with a bio-polymer substance that is made in the form of condensed liquid in the cold condition, but when faced with relatively warm temperatures of the human body takes the form of a jelly-like material.
The jelly come in the form of a substance that emits GLP-1 from very slowly and thus can control the amount of sugar in the blood for a long time. Type 2 diabetes found in experiments on infected mice and monkeys that this matter was due to have taken control blood sugar for up to 10 days in mice, while slightly slower metabolism (metabolism) to remain in the blood sugar control in monkeys Duration noted 17 days.
Experts say that in human metabolism speed is less than monkeys, it is expected that this substance will keep blood sugar control for one month in humans. However, the final confirmation will be possible only after preliminary tests on humans and human experiments have been requested for the relevant institutions.
If everything looks good, hope to be the next four to five years it will be available in the diabetes drug market and the type to take medication only once in 2 months will be enough diabetics.
Diabetes Like some glukugan 'in modern medicine peptides 1' or short 'GLP-1 (GLP1), called it a molecule which caused additional glucose amount that increases production of insulin in the body and thus the amount of blood sugar is controlled.
If, despite your best features GLP-1 when it reaches the human body is split over very quickly and thus unable to take advantage. Although GLP is to increase the sustainability of some of the more molecules (molecules) with 1 but then it ends dissolve within 3 to 7 days.
But under the new approach, scientists have GLP-1 can maintain its existence for more than two weeks in a body that is made to it, and that a long type 2 diabetics from insulin injection can be found.
Research journal 'Nature Biomedical Engineering, according to a report published in North Carolina, USA Duke University, a private research institute experts have been jointly working GLP 1 is combined with a bio-polymer substance that is made in the form of condensed liquid in the cold condition, but when faced with relatively warm temperatures of the human body takes the form of a jelly-like material.
The jelly come in the form of a substance that emits GLP-1 from very slowly and thus can control the amount of sugar in the blood for a long time. Type 2 diabetes found in experiments on infected mice and monkeys that this matter was due to have taken control blood sugar for up to 10 days in mice, while slightly slower metabolism (metabolism) to remain in the blood sugar control in monkeys Duration noted 17 days.
Experts say that in human metabolism speed is less than monkeys, it is expected that this substance will keep blood sugar control for one month in humans. However, the final confirmation will be possible only after preliminary tests on humans and human experiments have been requested for the relevant institutions.
If everything looks good, hope to be the next four to five years it will be available in the diabetes drug market and the type to take medication only once in 2 months will be enough diabetics.
Comments
Post a Comment